Tesamorelin: What It Is, What the Research Shows, and Is It Approved?

Tesamorelin is different from most peptides people read about online: it's an actual approved medicine, not a 'research chemical.' But that approval is for one specific medical situation, and it's prescription-only for good reasons. Here's the honest picture.

What tesamorelin actually is

Tesamorelin is a lab-made version of a natural body signal called growth-hormone-releasing hormone (GHRH). GHRH is a messenger your body already makes; its job is to tell the pituitary gland (a small gland in your brain) to release growth hormone. So instead of adding growth hormone directly, tesamorelin nudges your own body to release a bit more of its own.

What it's approved and used for

Tesamorelin is FDA-approved under the brand name Egrifta. Its approved use is quite specific: to reduce a particular kind of excess belly fat in people living with HIV who have a condition called lipodystrophy (a problem with how the body stores fat). It has also been studied in other settings, but that one use is what it's approved for.

What the evidence really shows

Because tesamorelin went through human clinical trials and earned FDA approval, there is real, reviewed evidence behind its approved use. That's a much stronger footing than the animal-only research behind many peptides. Even so, 'approved for one use' does not mean 'safe or proven for everything' — using it outside its approved purpose isn't backed by the same evidence.

Who talks about it — and why to be careful

In fitness and anti-aging circles, tesamorelin is sometimes discussed as a 'growth hormone' shortcut, and grey-market sellers offer 'research' versions. That's risky on two counts: you're using a hormone medicine outside a doctor's care, and the product may not be the real, checked medicine at all. The safe route is a doctor and a real prescription.

What this does not mean